ESR1 and breast carcinoma: High concentrations of E2 and signaling through ERα reduce NK-cell-induced death in breast cancer cell lines by increasing granzyme B inhibitors and proteinase inhibitor 9, whereas treatment of NK cells with tamoxifen impairs cytotoxicity [102].